This report incorporates an in-depth analysis of the spatial genomics and transcriptomics market, including market estimations and trends through 2021. Major players, competitive intelligence, innovative technologies, market dynamics and regional opportunities are discussed in detail. The report examines recent developments and product portfolios of major players. The product analysis focuses on recent technological trends in various regions, such as the U.S., Europe, and Japan. The report presents a market analysis and estimates the compound annual growth rate (CAGR) for spatial genomics and transcriptomics technologies.
The scope of the report covers only those spatial genomics and transcriptomics technologies that generate the most global revenue. Spatial genomics and transcriptomics are similar to spatial biology.
This report segments the global market by the geographic regions of North America, Europe, Asia-Pacific and the Rest of the World. For market estimates, data are provided for 2021 as the base year and forecast through the end of 2027.
Report Includes
- 34 data tables and 30 additional tables
- An overview of the global spatial genomics and transcriptomics market
- Analyses of global market trends with data from 2020-2022, and projections of compound annual growth rates (CAGRs) through 2027
- Estimation of the market size and highlights of the market potential by technology, end user, and application
- Detailed description of fluorescence In situ hybridization and microscopy RNA imaging and discussion on their application in the genomics industry
- Assessment of the current market size and forecast of market development in the coming five years, and insight into the value chain analysis, and factors driving and restraining the growth
- Information on recent mergers, acquisitions, collaborations, agreements, partnerships, product launches, and expansions in the global spatial genomics and transcriptomics market
- Identification of the major stakeholders and analysis of the competitive landscape based on recent developments, financial performance, and segmental revenues
- Company profiles of the leading global players, including Advanced Cell Diagnostics Inc., Bruker, Illumina, Standard BioTools Inc., Vizgen and Lunaphore
Table of Contents
Chapter 1 Introduction
1.1 Study Goals and Objectives
1.2 Reasons for Doing this Study
1.3 Scope of Report
1.4 Information Sources
1.5 Methodology
1.6 Geographic Breakdown
1.7 Analyst's Credentials
1.8 Custom Research
1.9 Related Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Market Overview
3.1 Spatial Genomics and Transcriptomics
3.1.1 Spatial Genomics
3.1.2 Spatial Transcriptomics
3.2 Spatial Transcriptomics Technologies
3.2.1 Fusion of Multiple Technologies
3.2.2 Spatial Genomics and Transcriptomics Provides Balance
3.3 Understanding Spatial Biology
3.4 Importance of Spatial Biology
3.5 Spatial Sequencing
3.6 Spatial Biology of Cancer Evolution
3.7 Innovation in Medical and Healthcare Products
3.8 Current Trends
3.8.1 Enhanced Cybersecurity
3.8.2 Internet of Medical Things
3.8.3 Medical Robots
3.8.4 Three-Dimensionally Printed Objects
3.8.5 Device Connectivity
3.8.6 Implications for Health Systems
3.9 Regulations and Legislation
3.9.1 Europe
3.9.2 U.S.
3.9.3 Japan
Chapter 4 Market Dynamics
4.1 Drivers
4.1.1 New Discoveries in Biological Sciences
4.1.2 Increasing Use of Bioinformatics Analytical Software
4.1.3 Antibody-Based Drug Discovery and Development
4.1.4 Developed and Increasing Research Areas
4.1.5 Application-Focused Technology Platforms
4.1.6 Strengthen Use and Adoption of Consumables
4.1.7 Increase in Infectious and Chronic Diseases
4.1.8 Relationships Among Biopharma Firms, Research Institutions and Medical Centers
4.2 Restraints
4.2.1 Labor-Intensive Technology and Products
4.3 Opportunities
4.3.1 Human Genome Project Development
4.3.2 Coming Revolution of Precision Medicine
4.4 Strategies
4.4.1 Trends
Chapter 5 Impact of the Covid-19 Pandemic
5.1 Impact of Covid-19 on Pharmaceutical and Biotech Industries
5.2 Short-Term Impact
5.2.1 Change in Demand
5.2.2 Shift of Communication and Promotions to Remote Interactions
5.2.3 Changes in R&D
5.3 Long-Term Impact
5.3.1 Delayed Approvals for Non-Covid-Related Pharmaceutical and Biotech Products
5.3.2 Self-Sufficiency in the Pharma and Biotech Industries
5.3.3 Pharmaceutical Industry Growth Slowdown
5.3.4 Changes in Consumption Trends in Health-Related Products
5.3.5 Potential Impact of Covid-19 on Genomic Study
Chapter 6 Business Model and Innovation
6.1 Business Model Innovation
Chapter 7 Global Spatial Genomics and Transcriptomics: Technology Market
7.1 Overview
7.2 Spatial Genomics
7.2.1 Market Outlook
7.3 Spatial Transcriptomics
7.3.1 Market Outlook
Chapter 8 Global Spatial Genomics and Transcriptomics Market by Product
8.1 Overview
8.2 Market for Spatial Genomics and Transcriptomics, by Product
8.3 Market Outlook
8.3.1 Consumables
8.3.2 Instruments
8.3.3 Software
Chapter 9 Global Spatial Genomics and Transcriptomics Market by Application
9.1 Overview
9.2 Spatial Genomics and Transcriptomics Market by Application
9.3 Market Outlook
9.3.1 Clinical and Translational Research
9.3.2 Drug Discovery and Development
Chapter 10 Global Spatial Genomics and Transcriptomics Market by End-user
10.1 Overview
10.2 Market for Spatial Genomics and Transcriptomics by End-user
10.3 Market Outlook
10.3.1 Academic and Research Institutes
10.3.2 Contract Research Organizations
10.3.3 Pharmaceutical and Biotechnology
Chapter 11 Global Spatial Genomics and Transcriptomics Market by Region
11.1 North America
11.1.1 Market Outlook
11.2 Europe
11.2.1 Market Outlook
11.3 Asia-Pacific
11.3.1 Market Outlook
11.4 Rest of the World
11.4.1 Market Outlook
Chapter 12 Competitive Landscape
Chapter 13 Company Profiles
- 10X Genomics
- Advanced Cell Diagnostics Inc.
- Akoya Biosciences Inc.
- Bruker Corp.
- Dovetail Genomics (Cantata Bio)
- Illumina
- Ionpath Inc.
- Lunaphore Technologies S.A.
- Nanostring Technologies
- Rarecyte Inc.
- Standard Biotools Inc.
- Vizgen Inc.
- Other Companies
List of Tables
Summary Table: Global Spatial Genomics and Transcriptomics Market, by Technology, Through 2027
Table 1: Differences Between Single-Cell RNA-Seq and RNA-Seq
Table 2: Class I and II Exempt Devices
Table 3: Akoya’s Relationship with Universities and Organizations
Table 4: Global Spatial Genomics and Transcriptomics Market, by Technology, Through 2027
Table 5: Global Spatial Genomics and Transcriptomics Market, by Genomics Technology, Through 2027
Table 6: Global Spatial Genomics and Transcriptomics Technologies Market, by Transcriptomics, Through 2027
Table 7: Global Spatial Genomics and Transcriptomics Market, by Product, Through 2027
Table 8: Global Spatial Genomics and Transcriptomics Market, by Application, Through 2027
Table 9: Global Spatial Genomics and Transcriptomics Market, by End User, Through 2027
Table 10: North American Spatial Genomics and Transcriptomics Market, by Technology, Through 2027
Table 11: North American Spatial Genomics and Transcriptomics Market, by Genomics Technology, Through 2027
Table 12: North American Spatial Genomics and Transcriptomics Technologies Market, by Transcriptomics, Through 2027
Table 13: North American Spatial Genomics and Transcriptomics Market, by Product, Through 2027
Table 14: North American Spatial Genomics and Transcriptomics Market, by Application, Through 2027
Table 15: North American Spatial Genomics and Transcriptomics Market, by End User, Through 2027
Table 16: North American Spatial Genomics and Transcriptomics Market, by Country, Through 2027
Table 17: European Spatial Genomics and Transcriptomics Market, by Technology, Through 2027
Table 18: European Spatial Genomics and Transcriptomics Market, by Genomics Technology, Through 2027
Table 19: European Spatial Genomics and Transcriptomics Technologies Market, by Transcriptomics, Through 2027
Table 20: European Spatial Genomics and Transcriptomics Market, by Product, Through 2027
Table 21: European Spatial Genomics and Transcriptomics Market, by Application, Through 2027
Table 22: European Spatial Genomics and Transcriptomics Market, by End User, Through 2027
Table 23: European Spatial Genomics and Transcriptomics Market, by Country, Through 2027
Table 24: Asia-Pacific Spatial Genomics and Transcriptomics Market, by Technology, Through 2027
Table 25: Asia-Pacific Spatial Genomics and Transcriptomics Technologies Market, by Transcriptomics, Through 2027
Table 26: Asia-Pacific Spatial Genomics and Transcriptomics Market, by Product, Through 2027
Table 27: Asia-Pacific Spatial Genomics and Transcriptomics Market, by Product, Through 2027
Table 28: Asia-Pacific Spatial Genomics and Transcriptomics Market, by Application, Through 2027
Table 29: Asia-Pacific Spatial Genomics and Transcriptomics Market, by End User, Through 2027
Table 30: Asia-Pacific Spatial Genomics and Transcriptomics Market, by Country, Through 2027
Table 31: RoW Spatial Genomics and Transcriptomics Market, by Technology, Through 2027
Table 32: RoW Spatial Genomics and Transcriptomics Market, by Genomics Technology, Through 2027
Table 33: RoW Spatial Genomics and Transcriptomics Technologies Market, by Transcriptomics, Through 2027
Table 34: RoW Spatial Genomics and Transcriptomics Market, by Product, Through 2027
Table 35: RoW Spatial Genomics and Transcriptomics Market, by Application, Through 2027
Table 36: RoW Spatial Genomics and Transcriptomics Market, by End User, Through 2027
Table 37: RoW Spatial Genomics and Transcriptomics Market, by Country, Through 2027
Table 38: Recent Company News, 2022
Table 39: 10xGenomics: Product Portfolio
Table 40: 10xGenomics: Recent Developments, 2020-2022
Table 41: Advanced Cell Diagnostics Inc.: Product Portfolio
Table 42: Advanced Cell Diagnostics Inc.: Recent Developments, 2019-2023
Table 43: Akoya Biosciences Inc.: Product Portfolio
Table 44: Akoya Biosciences Inc.: Recent Developments, 2020-2022
Table 45: Bruker: Product Portfolio
Table 46: Bruker: Recent Developments, 2021-2023
Table 47: Dovetail Genomics: Product Portfolio
Table 48: Dovetail Genomics: Recent Developments, 2019-2022
Table 49: Illumina: Product Portfolio
Table 50: Illumina: Recent Developments, 2020-2023
Table 51: Ionpath Inc.: Product Portfolio
Table 52: Ionpath Inc.: Recent Developments, 2020-2022
Table 53: Lunaphore: Product Portfolio
Table 54: Lunaphore: Recent Developments, 2022
Table 55: NanoString: Product Portfolio
Table 56: NanoString: Recent Developments, 2020-2022
Table 57: RareCyte: Product Portfolio
Table 58: RareCyte: Recent Developments, 2021 and 2022
Table 59: Standard BioTools Inc.: Product Portfolio
Table 60: Standard BioTools Inc.: Recent Developments, 2019-2022
Table 61: Vizgen: Product Portfolio
Table 62: Vizgen: Recent Developments, 2021-2023
Table 63: Other Spatial Genomics and Transcriptomics Startups
List of Figures
Summary Figure: Global Market for Spatial Genomics and Transcriptomics, by Genomics Technologies, 2019-2027
Figure 1: Spatial Transcriptomics Results from Fusion of Multiple Technologies
Figure 2: U.S. Medical Device Marketing Process
Figure 3: Global Projected Diabetes Incidence, Patients Age 20-79, 2010 and 2030
Figure 4: Global Infectious Diseases Incidence, Between 2020 and 2022
Figure 5: Global Infectious Diseases Outbreak, 2022
Figure 6: Impact of COVID-19 on the Pharmaceutical and Biotech Industries
Figure 7: Business Models' Five Interconnected Components
Figure 8: Lead Gears Drive the Business Model Shift
Figure 9: Global Market Shares of Spatial Genomics and Transcriptomics, by Technology, 2021
Figure 10: Global Market Shares of Spatial Genomics and Transcriptomics Technologies, by Genomics Technology, 2021
Figure 11: Global Market Shares of Spatial Genomics and Transcriptomics Technologies, by Transcriptomics, 2021
Figure 12: Global Market Shares of Spatial Genomics and Transcriptomics Technologies, by Product, 2021
Figure 13: Global Market Shares of Spatial Genomics and Transcriptomics, by Application, 2021
Figure 14: Growth of Multi-Omics in Different End Users
Figure 15: Global Market Shares of Spatial Genomics and Transcriptomics Technologies, by End User, 2021
Figure 16: North American Market Shares of Spatial Genomics and Transcriptomics, by Technology, 2021
Figure 17: North American Market Shares of Spatial Genomics and Transcriptomics Technologies, by Genomics Technology, 2021
Figure 18: North American Market Shares of Spatial Genomics and Transcriptomics Technologies Market, by Transcriptomics, 2021
Figure 19: North American Market Shares of Spatial Genomics and Transcriptomics Technologies, by Product, 2021
Figure 20: North American Market Shares of Spatial Genomics and Transcriptomics, by Application, 2021
Figure 21: North American Market Shares of Spatial Genomics and Transcriptomics Technologies, by End User, 2021
Figure 22: North American Market Shares of Spatial Genomics and Transcriptomics Technologies, by Country, 2021
Figure 23: U.S. Population Age 65 or Older, 2010-2050
Figure 24: European Market Shares of Spatial Genomics and Transcriptomics, by Technology, 2021
Figure 25: European Market Shares of Spatial Genomics and Transcriptomics Technologies, by Genomics Technologies, 2021
Figure 26: Figure 26 European Market Shares of Spatial Genomics and Transcriptomics Technologies Market, by Transcriptomics, 2021
Figure 27: European Market Shares of Spatial Genomics and Transcriptomics Technologies, by Product, 2021
Figure 28: European Market Shares of Spatial Genomics and Transcriptomics, by Application, 2021
Figure 29: European Market Shares of Spatial Genomics and Transcriptomics Technologies, by End User, 2021
Figure 30: European Market Shares of Spatial Genomics and Transcriptomics Technologies, by Country, 2021
Figure 31: Asia-Pacific Market Shares of Spatial Genomics and Transcriptomics, by Technology, 2021
Figure 32: Asia-Pacific Market Shares of Spatial Genomics and Transcriptomics Technologies, by Genomics Technology, 2021
Figure 33: Asia-Pacific Market Shares of Spatial Genomics and Transcriptomics Technologies Market, by Transcriptomics, 2021
Figure 34: Asia-Pacific Market Shares of Spatial Genomics and Transcriptomics Technologies, by Product, 2021
Figure 35: Asia-Pacific Market Shares of Spatial Genomics and Transcriptomics, by Application, 2021
Figure 36: Asia-Pacific Market Shares of Spatial Genomics and Transcriptomics Technologies, by End User, 2021
Figure 37: Asia-Pacific Market Shares of Spatial Genomics and Transcriptomics Technologies, by Country, 2021
Figure 38: RoW Market Shares of Spatial Genomics and Transcriptomics, by Technology, 2021
Figure 39: RoW Spatial Genomics and Transcriptomics Market Shares, by Genomics Technology, 2021
Figure 40: RoW Market Shares of Spatial Genomics and Transcriptomics Technologies, by Transcriptomics, 2021
Figure 41: RoW Market Shares of Spatial Genomics and Transcriptomics Technologies, by Product, 2021
Figure 42: RoW Market Shares of Spatial Genomics and Transcriptomics, by Application, 2021
Figure 43: RoW Market Shares of Spatial Genomics and Transcriptomics Technologies, by End User, 2021
Figure 44: RoW Market Shares of Spatial Genomics and Transcriptomics Technologies, by Country, 2021
Figure 45: Ranking of Spatial Genomics and Transcriptomics Companies, 2021
Figure 46: Ranking of Spatial Genomics and Transcriptomics Private Companies, 2021
Figure 47: 10xGenomics: Annual Revenue, 2019-2021
Figure 48: 10xGenomics: Revenue Share, by Business Segment, 2021
Figure 49: 10xGenomics: Revenue Share, by Region, 2021
Figure 50: Bio-Techne: Annual Revenue, 2020-2022
Figure 51: Bio-Techne: Revenue Share, by Business Segment, 2021
Figure 52: Akoya Biosciences Inc.: Annual Revenue, 2020 and 2021
Figure 53: Akoya Biosciences Inc.: Revenue Share, by Business Segment, 2021
Figure 54: Bruker: Annual Revenue, 2019-2021
Figure 55: Bruker: Revenue Share, by Business Segment, 2021
Figure 56: Illumina: Annual Revenue, 2019-2021
Figure 57: Illumina: Revenue Share, by Business Segment, 2021
Figure 58: NanoString: Annual Revenue, 2019-2021
Figure 59: NanoString: Revenue Share, by Business Segment, 2021
Executive Summary
The high growth rate of this segment is attributed to factors such as the demand of antibody research, the expanding COVID-19 pandemic, epidemics of other infectious diseases and an increase in R&D activities by key companies to develop new data regarding genetic consequences to counter the global rise in different infectious diseases. The advancement of biological discoveries will result in the need for more molecular targets to be detected by their antibodies and usage of different spatial genomics and transcriptomics instruments. Fulgent Genetics Inc., a technology-based genetic testing company focused on transforming patient care in oncology, infectious and rare diseases, and reproductive health, announced a strategic investment in Spatial Genomics Inc. a leading developer of sequential fluorescence in situ hybridization (seqFISH) technology. The company developed tests for COVID-19 and genetic testing, and it continues to develop new tests that are attractive to its various customer markets.
Spatial genomics and transcriptomics are growing at a high rate due to its advantages in genetic mapping, understanding of locations of infection genes and understanding of drug adaption according to the genetic module of disease. Demand for biomarkers for cancer, drugs for neurology diseases and the COVID-19 pandemic are also likely to propel market growth.
Technological advances in medical devices impact most therapeutic areas. The largest user segments are tissue engineering, drug discovery and regenerative medicine.
Fluorescence in situ hybridization has the advantages of locating the specific DNA sequences, diagnoses of genetic diseases, gene mapping and identification of novel oncogenes or genetic aberrations contributing to various types of cancers.
Advances in FISH techniques has also increased the demand for genomic in situ hybridization (GISH) and new probes locus-specific or whole chromosome probes.
The most widely used technologies in the genomics toolbox are bulk RNA sequencing (RNAseq), popular single-cell RNA sequencing (scRNAseq) and newly emerged spatial RNA sequencing (spRNAseq). Sequencing is one of the most widely used technologies for genomic study.
Companies Mentioned
- 10X Genomics
- Advanced Cell Diagnostics Inc.
- Akoya Biosciences Inc.
- Bruker Corp.
- Dovetail Genomics (Cantata Bio)
- Illumina
- Ionpath Inc.
- Lunaphore Technologies S.A.
- Nanostring Technologies
- Rarecyte Inc.
- Standard Biotools Inc.
- Vizgen Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 157 |
| Published | March 2023 |
| Forecast Period | 2022 - 2027 |
| Estimated Market Value ( USD | $ 1.5 Billion |
| Forecasted Market Value ( USD | $ 2.5 Billion |
| Compound Annual Growth Rate | 10.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 12 |
